NANCY E MILLS
Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology SLEEPY HOLLOW, NY NPI 1992775795
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology NY Acerta Pharma LLC All categories
General Payments — all program years on this page
$5,774.32
- Category: General Payments
- Program years: PY2018–2024
- Record count: 30
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $980.58 across 6 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $630.58 | 5 |
| Grant | $350.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $465.54 | 2 |
| Amgen Inc. | $139.93 | 1 |
| Genmab U.S., Inc. | $125.13 | 1 |
| Merck Sharp & Dohme Corporation | $125.00 | 1 |
| Daiichi Sankyo Inc. | $124.98 | 1 |
By program year
Records — PY2024 (6)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1089457680 | Daiichi Sankyo Inc. | $124.98 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104754652 | AstraZeneca Pharmaceuticals LP | $115.54 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105408115 | AstraZeneca Pharmaceuticals LP | $350.00 | 02/02/2024 | Grant | Undisputed | 01/23/2026 | View at CMS |
| 1117630957 | Amgen Inc. | $139.93 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1126830166 | Genmab U.S., Inc. | $125.13 | 04/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141855915 | Merck Sharp & Dohme LLC | $125.00 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.